These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 32658855)

  • 1. [Cardiovascular safety of hydroxychloroquine in the COVID-19 pandemic].
    Bozzo R; Ibelli F; Scublinsky D
    Medicina (B Aires); 2020; 80 Suppl 3():89-90. PubMed ID: 32658855
    [No Abstract]   [Full Text] [Related]  

  • 2. Recent Findings on Cardiovascular Safety With the Use of Chloroquine and Hydroxychloroquine for COVID-19.
    Guzman-Prado Y
    Am J Cardiol; 2020 Sep; 130():162-163. PubMed ID: 32624192
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of Hydroxychloroquine on Antibody Responses to the SARS-CoV-2 Coronavirus.
    de Miranda Santos IKF; Costa CHN
    Front Immunol; 2020; 11():1739. PubMed ID: 32849619
    [No Abstract]   [Full Text] [Related]  

  • 4. Hydroxychloroquine for Covid-19 - When the pandemic runs faster than research.
    Frigerio M
    Int J Cardiol; 2020 Oct; 316():285-286. PubMed ID: 32473921
    [No Abstract]   [Full Text] [Related]  

  • 5. Shining a light on the evidence for hydroxychloroquine in SARS-CoV-2.
    Ingraham NE; Boulware D; Sparks MA; Schacker T; Benson B; Sparks JA; Murray T; Connett J; Chipman JG; Charles A; Tignanelli CJ
    Crit Care; 2020 Apr; 24(1):182. PubMed ID: 32345336
    [No Abstract]   [Full Text] [Related]  

  • 6. Chloroquine and hydroxychloroquine for COVID-19: implications for cardiac safety.
    Jeevaratnam K
    Eur Heart J Cardiovasc Pharmacother; 2020 Jul; 6(4):256-257. PubMed ID: 32347923
    [No Abstract]   [Full Text] [Related]  

  • 7. The impact of hydroxychloroquine shortages on patients with dermatological conditions during COVID-19 pandemic.
    Shah M; Sachdeva M; Dodiuk-Gad RP
    Dermatol Ther; 2020 Jul; 33(4):e13524. PubMed ID: 32383251
    [No Abstract]   [Full Text] [Related]  

  • 8. Hydroxychloroquine, Coronavirus Disease 2019, and QT Prolongation.
    Bonow RO; Hernandez AF; Turakhia M
    JAMA Cardiol; 2020 Sep; 5(9):986-987. PubMed ID: 32936259
    [No Abstract]   [Full Text] [Related]  

  • 9. Optimal dosing & time: Issues to get hydroxychloroquine safety & efficacy against COVID-19/SARS-CoV-2.
    Neves FS
    Indian J Med Res; 2020 Jul & Aug; 152(1 & 2):124-126. PubMed ID: 32801224
    [No Abstract]   [Full Text] [Related]  

  • 10. Re: Chloroquine (CQ) and Hydroxychloroquine (HQ) Retinal Toxicity Consideration in the Treatment of the Coronavirus Disease 2019 (COVID-19).
    Ruamviboonsuk P; Lai TYY; Chang A; Lai CC; Mieler WF; Lam DSC
    Asia Pac J Ophthalmol (Phila); 2020; 9(4):375-376. PubMed ID: 32740072
    [No Abstract]   [Full Text] [Related]  

  • 11. Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.
    Avidan MS; Dehbi HM; Delany-Moretlwe S
    N Engl J Med; 2020 Sep; 383(11):1087-1088. PubMed ID: 32668106
    [No Abstract]   [Full Text] [Related]  

  • 12. The 11th Trial of a Cardiovascular Clinical Trialist: Coronavirus-2: Part 2.
    Frishman WH
    Cardiol Rev; 2020; 28(5):217-218. PubMed ID: 32639241
    [No Abstract]   [Full Text] [Related]  

  • 13. The Saga of Hydroxychloroquine and COVID-19: A Cautionary Tale.
    Schluger NW
    Ann Intern Med; 2020 Oct; 173(8):662-663. PubMed ID: 32673059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydroxychloroquine as Postexposure Prophylaxis for Covid-19. Reply.
    Okafor EC; Pastick KA; Rajasingham R
    N Engl J Med; 2020 Sep; 383(11):1089. PubMed ID: 32668109
    [No Abstract]   [Full Text] [Related]  

  • 15. Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.
    Tekwani BL
    N Engl J Med; 2020 Sep; 383(11):1088-1089. PubMed ID: 32668108
    [No Abstract]   [Full Text] [Related]  

  • 16. Hydroxychloroquine as Postexposure Prophylaxis for Covid-19.
    Khan MS; Butler J
    N Engl J Med; 2020 Sep; 383(11):1088. PubMed ID: 32668107
    [No Abstract]   [Full Text] [Related]  

  • 17. Aminoquinolines against coronavirus disease 2019 (COVID-19): chloroquine or hydroxychloroquine.
    Sahraei Z; Shabani M; Shokouhi S; Saffaei A
    Int J Antimicrob Agents; 2020 Apr; 55(4):105945. PubMed ID: 32194152
    [No Abstract]   [Full Text] [Related]  

  • 18. Hydroxychloroquine for Coronavirus: The Urgent Need for a Moratorium on Prescriptions.
    Shih RD; Johnson HM; Maki DG; Hennekens CH
    Am J Med; 2020 Sep; 133(9):1007-1008. PubMed ID: 32502485
    [No Abstract]   [Full Text] [Related]  

  • 19. Hydroxychloroquine use in COVID-19: what is the basis for baseline tests?
    Afra TP; T MR; Bishnoi A; Hafi NB
    Lancet Infect Dis; 2020 Oct; 20(10):1120-1121. PubMed ID: 32559452
    [No Abstract]   [Full Text] [Related]  

  • 20. Evidence of Protective Effect of Hydroxychloroquine on COVID-19.
    Joob B; Wiwanitkit V
    J Rheumatol; 2020 Oct; 47(10):1587. PubMed ID: 32451353
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.